|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| C07K 16/46 | (2006.01) |
| (11) | Number of the document | 2838920 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13726321.6 |
| Date of filing the European patent application | 2013-04-16 | |
| (97) | Date of publication of the European application | 2015-02-25 |
| (45) | Date of publication and mention of the grant of the patent | 2017-02-01 |
| (46) | Date of publication of the claims translation | 2017-05-25 |
| (86) | Number | PCT/US2013/036677 |
| Date | 2013-04-16 |
| (87) | Number | WO 2013/158577 |
| Date | 2013-10-24 |
| (30) | Number | Date | Country code |
| 201261636302 P | 2012-04-20 | US | |
| 201361768747 P | 2013-02-25 | US |
| (72) |
ALLAN, Barrett, US
BENSCHOP, Robert Jan, US
LU, Jirong, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Bispecifiniai anti-BAFF-anti-IL-17 antikūnai |
| ANTI-BAFF-ANTI-IL-17 BISPECIFIC ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2021-03-23 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-04-16 |